NeoGenomics, Inc. Deferred Revenue Recognized
NeoGenomics, Inc. (NEO) reported Deferred Revenue Recognized of $300.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-07-28
- NeoGenomics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2026-06-30 was $300.00K, a 650.00% increase year-over-year.
- NeoGenomics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $500.00K, a 400.00% increase year-over-year.
- NeoGenomics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-09-30 was $10.00K, a 90.00% decline year-over-year.
- NeoGenomics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-06-30 was $40.00K, a 86.67% decline year-over-year.
- NeoGenomics, Inc. contract with customer, liability, revenue recognized for fiscal 2025 was $300.00K, a 81.25% decline from fiscal 2024.
- NeoGenomics, Inc. contract with customer, liability, revenue recognized for fiscal 2024 was $1.60M, a 75.00% decline from fiscal 2023.
- NeoGenomics, Inc. contract with customer, liability, revenue recognized for fiscal 2023 was $6.40M, a 23.08% increase from fiscal 2022.
- NeoGenomics, Inc. contract with customer, liability, revenue recognized for fiscal 2022 was $5.20M, a 18.18% increase from fiscal 2021.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $300.00K 10-Q · filed 2026-07-28 | $800.00K 10-Q · filed 2026-07-28 | ||
| 2026-03-31 | $500.00K 10-Q · filed 2026-04-28 | |||
| 2025-12-31 | $300.00K 10-K · filed 2026-02-17 | |||
| 2025-09-30 | $10.00K 10-Q · filed 2025-10-28 | $100.00K 10-Q · filed 2025-10-28 | ||
| 2025-06-30 | $40.00K 10-Q · filed 2026-07-28 | $100.00K 10-Q · filed 2026-07-28 | ||
| 2025-03-31 | $100.00K 10-Q · filed 2026-04-28 | |||
| 2024-12-31 | $1.60M 10-K · filed 2026-02-17 | |||
| 2024-09-30 | $100.00K 10-Q · filed 2025-10-28 | $1.50M 10-Q · filed 2025-10-28 | ||
| 2024-06-30 | $300.00K 10-Q · filed 2025-07-29 | $1.40M 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | $1.10M 10-Q · filed 2025-04-29 | |||
| 2023-12-31 | $6.40M 10-K · filed 2026-02-17 | |||
| 2023-09-30 | $1.40M 10-Q · filed 2024-11-05 | $4.90M 10-Q · filed 2024-11-05 | ||
| 2023-06-30 | $1.70M 10-Q · filed 2024-07-30 | $3.50M 10-Q · filed 2024-07-30 | ||
| 2023-03-31 | $1.80M 10-Q · filed 2024-04-30 | |||
| 2022-12-31 | $5.20M 10-K · filed 2025-02-18 | |||
| 2022-09-30 | $700.00K 10-Q · filed 2023-11-06 | $4.80M 10-Q · filed 2023-11-06 | ||
| 2022-06-30 | $1.00M 10-Q · filed 2023-08-08 | $4.10M 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $3.10M 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $4.40M 10-K · filed 2024-02-20 | |||
| 2021-09-30 | $400.00K 10-Q · filed 2022-11-08 | $4.20M 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $1.10M 10-Q · filed 2022-08-09 | $3.80M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $2.70M 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $2.30M 10-K · filed 2023-02-24 | |||
| 2020-09-30 | $500.00K 10-Q · filed 2021-11-04 | $2.10M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $400.00K 10-Q · filed 2021-08-09 | $1.60M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $1.20M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $2.20M 10-K · filed 2022-02-25 | |||
| 2019-09-30 | $100.00K 10-Q · filed 2019-11-13 | $2.00M 10-Q · filed 2019-11-13 | ||
| 2019-06-30 | $600.00K 10-Q · filed 2019-08-07 | $1.90M 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | $1.30M 10-Q · filed 2020-04-29 | |||
| 2018-12-31 | $1.60M 10-K · filed 2019-02-26 | |||
| 2018-09-30 | $200.00K 10-Q · filed 2018-11-06 | $1.50M 10-Q · filed 2018-11-06 | ||
| 2018-06-30 | $300.00K 10-Q · filed 2018-08-06 | $1.30M 10-Q · filed 2018-08-06 | ||
| 2018-03-31 | $900.00K 10-Q · filed 2019-05-08 | |||
| 2017-03-31 | $300.00K 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |